Total Knee Replacement Surgery

Total knee replacement surgery — formally termed total knee arthroplasty (TKA) — is one of the most performed elective orthopedic procedures in the United States, with the American Academy of Orthopaedic Surgeons (AAOS) reporting that approximately 790,000 procedures are performed annually. This page covers the anatomical scope of the operation, the surgical mechanism and implant types, the clinical conditions that typically lead to this intervention, and the decision thresholds used to determine candidacy. Understanding these parameters is foundational to any informed discussion of orthopedic care and its regulatory environment.

Definition and scope

Total knee replacement surgery involves the surgical resurfacing of all three compartments of the knee joint: the medial (inner) compartment, the lateral (outer) compartment, and the patellofemoral compartment between the kneecap and femur. The damaged cartilage and a thin layer of underlying bone are removed and replaced with metal alloy components fixed to the femur and tibia, with a high-density polyethylene spacer inserted between them to replicate cartilage function.

The procedure is distinct from a partial knee replacement (unicompartmental arthroplasty), which resurfaces only one compartment when disease is isolated. TKA addresses disease across the full joint surface and accounts for the majority of knee arthroplasty volume in the U.S.

Implant devices are regulated by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act as Class II or Class III medical devices, depending on design novelty. Most contemporary TKA implants receive clearance through the FDA's 510(k) premarket notification pathway, which requires demonstration of substantial equivalence to a legally marketed predicate device (FDA 510(k) Program).

The broad landscape of orthopedic procedures and specialties provides useful context for situating TKA within the full scope of musculoskeletal medicine.

How it works

The surgical sequence for total knee replacement follows a structured, phase-based protocol:

1. Anesthesia — General, spinal, or regional nerve block anesthesia is administered. Spinal anesthesia combined with a peripheral nerve block has become a dominant approach in enhanced recovery pathways.
2. Exposure — A midline anterior incision, typically 8–12 cm in length, is made. The quadriceps tendon and patella are mobilized to expose the joint.
3. Bone preparation — Cutting guides aligned to mechanical axis measurements direct the removal of precise thicknesses of bone from the distal femur, proximal tibia, and posterior patella. Alignment accuracy to within 3 degrees of the mechanical axis is a standard surgical benchmark cited in orthopedic literature.
4. Component sizing and trialing — Provisional implants are inserted to assess flexion, extension, and balance of the soft tissue envelope before final fixation.
5. Final fixation — Femoral and tibial metal components are cemented (polymethylmethacrylate, PMMA) or press-fit (cementless) depending on bone quality and patient age. Cementless fixation relies on osseointegration — bone ingrowth into porous implant surfaces.
6. Closure and recovery — Drains may be placed, the capsule and soft tissue are closed in layers, and the patient transitions to a recovery protocol.

Posterior cruciate-retaining (CR) designs preserve the posterior cruciate ligament (PCL) to guide knee kinematics. Posterior-stabilized (PS) designs substitute the PCL with a cam-and-post mechanism built into the implant. The choice between CR and PS configurations depends on ligament integrity at surgery and surgeon preference.

Robotic-assisted and computer-navigated systems, cleared by the FDA under relevant 510(k) submissions, are now employed in a significant proportion of TKA procedures at high-volume centers to improve alignment precision.

Common scenarios

Total knee replacement is indicated most consistently for end-stage joint destruction. The clinical scenarios in which TKA is performed fall into three primary categories:

Osteoarthritis — Primary osteoarthritis represents the leading indication for TKA, accounting for the majority of all cases. Cartilage loss, subchondral bone sclerosis, osteophyte formation, and joint space narrowing visible on weight-bearing radiographs characterize end-stage disease.

Inflammatory arthropathy — Rheumatoid arthritis and related inflammatory joint diseases can destroy the knee joint through synovitis-driven cartilage erosion. Patients with inflammatory arthropathies typically present at younger ages than osteoarthritis patients.

Post-traumatic arthritis — Prior fractures involving the tibial plateau or distal femur, or untreated ligamentous instability following ACL tears or meniscus tears, can lead to accelerated joint degeneration requiring arthroplasty.

Avascular necrosis (AVN) of the femoral condyle, though less common than the above, can also progress to joint collapse requiring TKA.

Decision boundaries

The decision to proceed with TKA is not based on imaging findings alone. The AAOS Clinical Practice Guidelines on osteoarthritis of the knee specify that surgical candidacy depends on the convergence of radiographic severity, functional limitation, and failure of non-operative management.

Key thresholds used in clinical decision-making:

• Conservative treatment exhaustion — Candidates have typically completed structured physical therapy and rehabilitation, a trial of bracing or assistive devices, and appropriate pharmacologic or injection-based management.
• Functional impact — Pain that limits activities of daily living, disrupts sleep, or prevents weight-bearing ambulation is a primary trigger for surgical referral.
• Radiographic confirmation — Kellgren-Lawrence Grade 3 or Grade 4 changes on weight-bearing anteroposterior radiographs are the standard imaging threshold. Grade 4 represents complete or near-complete joint space obliteration.
• Patient health status — Surgical risk is stratified using the American Society of Anesthesiologists (ASA) Physical Status Classification. Patients with ASA Class III or higher require coordinated medical optimization before proceeding.
• Age and activity level — Implant longevity data from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) and the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR) indicate cumulative revision rates that inform age-based timing discussions.

Total knee replacement is contraindicated in active joint infection, absent extensor mechanism, and severe peripheral vascular disease affecting wound healing. Morbid obesity (BMI above 40) is a relative contraindication at many institutions based on elevated complication and revision rates documented in registry data.

The process of recovering from joint replacement and rehabilitation after orthopedic surgery are distinct phases that begin immediately after the procedure and extend for 3–6 months in structured programs.

References

• American Academy of Orthopaedic Surgeons (AAOS) — Knee Replacement Information
• FDA — Premarket Notification 510(k) Program for Medical Devices
• Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR)
• National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR)
• AAOS Clinical Practice Guideline — Management of Osteoarthritis of the Knee
• American Society of Anesthesiologists (ASA) — Physical Status Classification System

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)